PVC EVOH LDPE
WALLIS
| Color: | |
|---|---|
| Size: | |
| advantage: | |
| Availability: | |
| Quantity: | |
Wallis supplies PVC/EVOH/LDPE high-barrier rigid sheet for pharmaceutical, medical, diagnostic, nutraceutical and specialty healthcare packaging applications. The multilayer structure combines a rigid PVC forming layer, an EVOH oxygen-barrier layer and an LDPE sealing layer to provide a balance of thermoforming performance, gas protection and heat-seal functionality.
The material can be supplied in rolls or pre-cut sheets with customized thickness, width, color, opacity and layer construction. It can be evaluated for thermoformed cavities, rigid trays, unit-dose packaging, diagnostic reagent packaging and other converted packaging formats.
For pharmaceutical and medical applications, final material selection should be based on the required oxygen transmission rate, water-vapor transmission rate, forming depth, sealing system, packaged formulation, sterilization process and destination-market regulatory requirements. Physical qualification of the complete package is recommended before commercial production.
A multilayer packaging structure combines different polymers because no single material provides optimum rigidity, oxygen barrier, moisture protection, sealing and processing performance for every application.
PVC forms the primary rigid or semi-rigid structural layer. It provides dimensional stability and supports heating, cavity formation, cutting and other packaging-conversion processes.
EVOH is primarily selected for its very low oxygen and gas permeability. Incorporating a relatively thin EVOH barrier layer can significantly improve the oxygen-barrier performance of a multilayer package compared with conventional commodity polymers.
EVOH barrier performance is affected by humidity, so the EVOH layer is normally protected inside the multilayer structure rather than being used as an exposed moisture-barrier layer.
LDPE can function as a sealing layer and can help protect the EVOH barrier from moisture exposure. The final moisture-barrier performance depends on LDPE thickness, the complete laminate structure and the environmental conditions used for testing.
The following values represent the current typical Wallis product range. Final tolerances, layer ratios and functional performance should be confirmed for each medical or pharmaceutical packaging project.
| Parameter | Typical Specification / Notes |
|---|---|
| Product | PVC/EVOH/LDPE High-Barrier Rigid Packaging Sheet |
| Structure | PVC structural layer / EVOH oxygen-barrier layer / LDPE sealing layer |
| Total Thickness | Approximately 0.055–2.00 mm; customized according to application |
| Layer Ratio | Customized according to target OTR, WVTR, rigidity, forming depth and sealing requirements |
| Width | Approximately 50–1400 mm |
| Supply Format | Rolls or pre-cut sheets |
| Typical Density | Approximately 1.3–1.5 g/cm³, subject to final structure |
| Color | Transparent, white, yellow, transparent orange and customized colors |
| Oxygen Barrier | High oxygen-barrier performance provided by EVOH; specify target OTR and test conditions |
| Moisture Barrier | Depends on LDPE, total multilayer structure, thickness and test conditions; specify target WVTR |
| Heat-Sealing Layer | LDPE; compatibility with the mating lidding material must be validated |
| Processing | Thermoforming, cutting, sealing, printing and project-specific converting |
| Customization | Thickness, layer ratio, width, sheet size, color, opacity, surface and roll configuration |
PVC/EVOH/LDPE Composite Rigid Sheet
PVC/EVOH/LDPE Pharmaceutical Packaging
Oxygen barrier and moisture barrier are different packaging properties and should be specified separately. A material described simply as “high barrier” does not provide enough technical information for pharmaceutical packaging selection.
EVOH is used primarily because of its excellent resistance to oxygen and other gas transmission. This can be valuable for products susceptible to oxidative degradation.
EVOH itself is sensitive to moisture. LDPE and other surrounding polymer layers help isolate EVOH from water and contribute to the total moisture-barrier performance of the finished laminate.
Highly hygroscopic pharmaceutical products may require stronger water-vapor protection than a standard PVC/EVOH/LDPE structure can provide. Depending on stability data, a PVDC-, PCTFE- or other specialized high-moisture-barrier construction may need to be evaluated.
OTR measures oxygen permeation through the packaging structure under defined conditions. Buyers should provide the target value together with test temperature, relative humidity, test area and applicable method.
WVTR measures water-vapor transmission and should be specified independently from OTR. Required WVTR depends on product moisture sensitivity and expected storage environment.
OTR and WVTR values can change significantly with temperature, humidity and material thickness. Supplier values should therefore be compared only when the test conditions are equivalent.
Thermoforming stretches the multilayer material and reduces layer thickness at cavity walls and corners. For critical applications, barrier performance should be evaluated on the formed package as well as on the original flat sheet.
The EVOH layer significantly reduces oxygen permeation compared with conventional commodity polymer structures and can support packaging development for oxygen-sensitive products.
PVC provides a stable structural base for thermoforming, helping create rigid cavities, trays and other converted packaging components.
The LDPE layer creates a functional sealant surface and can be matched to suitable lidding or mating structures after seal testing.
Transparent structures can provide product visibility while maintaining an EVOH oxygen-barrier layer. Colored and opaque versions can also be discussed for projects requiring a different visual appearance.
Total thickness and individual layer proportions can be evaluated according to required stiffness, barrier level, cavity geometry, sealing conditions and converting process.

Heat-seal performance depends on the complete sealing system. LDPE can provide an effective sealant layer, but seal strength cannot be predicted from the polymer name alone.
Buyers should provide the exact aluminum foil, laminated film, peelable lidding or other mating structure because different sealants and coatings require different conditions.
Seal initiation temperature, dwell time, pressure and line speed should be established using the actual packaging machine and lidding material.
Finished packages should be checked for seal strength, channels, leakage and integrity under expected transportation and storage conditions.
PVC/EVOH/LDPE can be developed for thermoformed packaging, but the complete layer structure should be evaluated under the intended forming conditions.
Heating conditions must allow sufficient PVC forming while avoiding damage to the laminate interface or excessive distortion of the finished part.
Deeper cavities create greater material stretching. Provide cavity width, length, depth and corner geometry when evaluating a new multilayer specification.
Critical oxygen-sensitive products should be evaluated using formed-package barrier testing because EVOH thickness can vary across the cavity after stretching.
The laminate should be examined after forming for interlayer separation, whitening, cracking or other structural changes before commercial approval.
PVC/EVOH/LDPE can be evaluated for tablets, capsules and other solid-dosage products where oxygen protection, forming behavior and seal integrity are important. Highly moisture-sensitive products should be evaluated separately against stronger moisture-barrier structures.
Diagnostic reagents and test components can benefit from oxygen-barrier packaging, but compatibility should be verified with the actual reagent formulation, contact layer and intended storage conditions.
Selected liquid or unit-dose packaging applications can be evaluated where the LDPE contact layer, seal design and chemical compatibility are appropriate for the formulation.
The rigid multilayer structure can be evaluated for medical or healthcare trays requiring thermoforming and oxygen-barrier performance. Sterile medical-device packaging requires separate qualification of the complete package and sterilization process.
Oxygen-sensitive vitamins, supplements and nutraceutical formulations can be candidates for EVOH-based packaging when the complete barrier specification matches the product-stability requirement.
PVC/EVOH/LDPE Pharmaceutical Packaging
PVC/EVOH/LDPE Medical Packaging
Pharmaceutical Solid Dosage & Liquids
Capsule Packaging
| Structure | Main Barrier Focus | Typical Selection Logic |
|---|---|---|
| PVC/PE | Forming + sealing | Use when standard barrier levels are sufficient |
| PVC/EVOH/LDPE | Enhanced oxygen / gas barrier + sealing | Evaluate for oxygen-sensitive products requiring transparent thermoformable packaging |
| PVC/PVDC | Enhanced moisture and oxygen barrier | Common option where stronger moisture protection is required |
| PVC/PE/PVDC | Sealing plus enhanced moisture / gas barrier | Evaluate according to forming, sealing and barrier requirements |
| PCTFE-Based Structure | Very high moisture barrier | Consider for highly moisture-sensitive products based on stability data |
A multilayer packaging sheet should not be described as universally compatible with all pharmaceuticals, solvents, oils, diagnostic reagents or biologic formulations. Compatibility depends on the exact contact layer and packaged product.
Where LDPE is the product-contact surface, its exact grade, additives and compatibility should be evaluated according to the packaged formulation.
Liquids, reagents, oils and solvent-containing formulations should be tested for swelling, stress cracking, extraction, migration, discoloration and changes in seal or barrier performance.
High-barrier packaging can contribute to product protection, but the packaging material itself cannot guarantee a specific pharmaceutical shelf life. Final shelf life should be established through the manufacturer's stability program.
Sterilization suitability depends on the exact PVC/EVOH/LDPE construction and the sterilization technology. Do not assume one structure is automatically compatible with steam, dry heat, ethylene oxide, gamma radiation, electron beam or other processes.
Buyers should provide sterilization temperature, pressure, radiation dose, exposure time and number of cycles where applicable. The finished package should then be checked for deformation, discoloration, delamination, seal-strength change and barrier retention.
Medical and pharmaceutical packaging qualification should be based on documentation for the exact material grade purchased. A general statement such as “medical grade” or “pharmaceutical grade” does not replace application-specific regulatory review.
Buyers should request a technical specification covering the exact structure, thickness, tolerance, width and relevant functional properties.
Where required by the customer's quality system, the actual production batch should be supported by the agreed COA rather than relying on a certificate from a different material structure.
The existing Wallis page includes the following PVC and PVDC reference documents. Because this product is PVC/EVOH/LDPE rather than PVC/PVDC, buyers should request documents specifically applicable to the actual PVC/EVOH/LDPE grade being qualified.
Confirm oxygen-barrier performance under the test conditions relevant to the finished product and storage environment.
Measure water-vapor transmission independently where the pharmaceutical formulation is moisture sensitive.
Evaluate cavity formation, thickness distribution, whitening, cracking and interlayer stability on the intended forming equipment.
Test the exact LDPE surface together with the intended lidding material to establish a practical production sealing window.
Direct-contact applications should be tested using the actual pharmaceutical, diagnostic or healthcare formulation.
Packaging qualification should include representative storage, transportation and stability conditions before the material is approved for commercial use.
Total thickness can be discussed within the production range according to stiffness, cavity geometry and final packaging construction.
The EVOH layer should be designed according to the required oxygen-barrier target rather than selecting an arbitrary thickness ratio.
LDPE thickness and grade can be evaluated according to the lidding material, sealing method and product-contact requirements.
Roll widths and pre-cut dimensions can be matched to thermoforming, sealing and converting equipment within the available production range.
Transparent, white, yellow, transparent orange and customized colors can be discussed. Light-protection requirements should be defined separately where pharmaceutical photostability is important.
Identify whether the package contains tablets, capsules, powders, diagnostic reagents, liquids, medical components or another product.
Provide PVC/EVOH/LDPE layer requirements or the current TDS if replacing an existing material.
Specify the target total thickness and individual layer requirements if already established.
Provide the required oxygen transmission rate together with temperature, relative humidity and test method.
Provide the required water-vapor transmission rate and relevant test conditions where moisture protection is critical.
Specify roll width, sheet size, core size and maximum roll dimensions according to the converting equipment.
Include forming-machine model, cavity dimensions, draw depth and existing temperature range where available.
Identify the mating lidding material together with sealing temperature, pressure, dwell time and production speed.
If applicable, provide sterilization method, temperature or radiation dose, exposure time and cycle requirements.
Provide the destination country and applicable pharmaceutical, medical-device, product-contact or customer-specific documentation requirements.
Include sample quantity, qualification quantity, initial bulk order and expected annual purchasing volume where available.

Pharmaceutical Material Packaging Production Line
Customer Cooperation
International B2B Cooperation
Packaging Exhibition
Pharmaceutical Packaging Exhibition

It is a multilayer rigid or semi-rigid packaging structure combining PVC for structural support and thermoforming, EVOH for oxygen and gas barrier, and LDPE for sealing and moisture protection.
EVOH is primarily used to reduce oxygen and gas transmission. It is particularly useful when the packaged product is sensitive to oxidative degradation.
EVOH is mainly an oxygen and gas barrier and is sensitive to moisture. The surrounding LDPE and other polymer layers protect EVOH and contribute to the complete structure's moisture performance. Highly moisture-sensitive products may require another dedicated high-moisture-barrier structure.
The current Wallis product range lists approximately 0.055–2.00 mm total thickness. Final layer ratios and thickness tolerances should be confirmed according to the required barrier, forming and sealing performance.
The current product range lists widths of approximately 50–1400 mm, with rolls and pre-cut sheets available according to the project.
Current options include transparent, white, yellow and transparent orange, with additional custom colors and opacity levels subject to project requirements.
Suitable structures can be thermoformed into cavities or trays. Forming temperature, cavity depth, draw ratio and barrier retention should be validated using the actual production equipment.
Deep-draw applications can be evaluated, but greater forming depth causes more material stretching. Layer stability, wall thickness and formed-package barrier should therefore be checked before approval.
Seal compatibility depends on the LDPE grade and the aluminum foil's heat-seal coating. The actual forming web and lidding foil should be tested together to establish the correct sealing window.
The correct OTR depends on the packaged product's oxygen sensitivity and required shelf life. Provide the target value together with temperature, relative humidity and the intended test method.
Required WVTR depends on the product's moisture sensitivity and storage environment. Highly hygroscopic products may require a structure specifically optimized for stronger water-vapor protection.
PVC/EVOH/LDPE places strong emphasis on EVOH oxygen barrier combined with LDPE sealing. PVC/PVDC structures are commonly selected when both moisture and gas barrier need to be increased. The correct structure should be selected from actual stability and barrier requirements.
It depends on the required WVTR and total package design. For very moisture-sensitive drugs, PVDC-, PCTFE- or another dedicated high-moisture-barrier structure may need to be evaluated.
Compatibility cannot be assumed for every formulation. Direct-contact applications should be tested using the actual liquid or reagent together with the selected LDPE contact layer.
Sterilization compatibility depends on the exact multilayer construction and sterilization process. Provide the method, temperature, dose or pressure and cycle conditions so package performance can be evaluated.
No generic material name guarantees regulatory approval for every application. Qualification depends on the exact grade, product-contact conditions, dosage form, destination market and applicable regulatory or customer requirements.
Yes. Sample evaluation is recommended for OTR, WVTR, thermoforming, heat sealing, product compatibility, thickness, color and production-line testing before commercial approval.
Please provide the packaged product, required structure, total thickness, target OTR and WVTR, roll or sheet dimensions, forming conditions, lidding material, sealing conditions, sterilization requirements, regulatory requirements and estimated purchasing quantity.
Send Wallis your required structure, thickness, width, OTR/WVTR targets, cavity dimensions, sealing system, product-contact requirements and estimated purchasing quantity. We can discuss customized PVC/EVOH/LDPE rigid sheets for pharmaceutical, diagnostic and medical packaging projects.
If you are replacing an existing high-barrier material, provide the current TDS, formed package or reference sample so barrier, thermoforming and sealing requirements can be evaluated before commercial production.
Start Your Project with Us